Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry D Moerland

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.
Cardiovascular Research|May 19, 2022
Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory stateLaura A Bosmans, Claudia M van Tiel, Suzanne A B M Aarts, et al.
European Journal of Immunology|July 17, 2015
Blimp-1 homolog Hobit identifies effector-type lymphocytes in humansFelipe A Vieira Braga, Kirsten M L Hertoghs, Natasja A M Kragten, et al.
Nature Aging|April 12, 2024
A conserved complex lipid signature marks human muscle aging and responds to short-term exerciseGeorges E Janssens, Marte Molenaars, Katharina Herzog, et al.
Biochemical Pharmacology|January 2, 2026
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapyDaniel J de Klerk, Mark J de Keijzer, Leonardo P Franchi, et al.
Journal of the American Heart Association|July 21, 2022
Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor StudyJan M Leerink, Elizabeth A M Feijen, Perry D Moerland, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Journal of the American College of Cardiology|February 7, 2018
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces AtherosclerosisTom T P Seijkens, Claudia M van Tiel, Pascal J H Kusters, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.
Cardiovascular Research|May 19, 2022
Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory stateLaura A Bosmans, Claudia M van Tiel, Suzanne A B M Aarts, et al.
European Journal of Immunology|July 17, 2015
Blimp-1 homolog Hobit identifies effector-type lymphocytes in humansFelipe A Vieira Braga, Kirsten M L Hertoghs, Natasja A M Kragten, et al.
Nature Aging|April 12, 2024
A conserved complex lipid signature marks human muscle aging and responds to short-term exerciseGeorges E Janssens, Marte Molenaars, Katharina Herzog, et al.
Biochemical Pharmacology|January 2, 2026
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapyDaniel J de Klerk, Mark J de Keijzer, Leonardo P Franchi, et al.
Journal of the American Heart Association|July 21, 2022
Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor StudyJan M Leerink, Elizabeth A M Feijen, Perry D Moerland, et al.
Nature Communications|August 4, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spikeMathieu Claireaux, Tom G Caniels, Marlon de Gast, et al.
Journal of the American College of Cardiology|February 7, 2018
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces AtherosclerosisTom T P Seijkens, Claudia M van Tiel, Pascal J H Kusters, et al.
Pageof 10